Phase 1/2 study of nivolumab with or without ipilimumab for treatment of recurrent small cell lung cancer (SCLC): CA209-032 Meeting Abstract
| Authors: | Antonia, S. J.; Bendell, J.; Taylor, M.; Calvo, E.; Jäger, D.; De Braud, F.; Ott, P. A.; Pietanza, M. C.; Horn, L.; Le, D. T.; Morse, M. A.; Lopez-Martin, J. A.; Ascierto, P. A.; Christensen, O.; Grosso, J. F.; Simon, J.; Lin, C.; Eder, J. P. |
| Abstract Title: | Phase 1/2 study of nivolumab with or without ipilimumab for treatment of recurrent small cell lung cancer (SCLC): CA209-032 |
| Meeting Title: | 17th National Congress of Medical Oncology |
| Journal Title: | Annals of Oncology |
| Volume: | 26 |
| Issue: | Suppl. 6 |
| Meeting Dates: | 2015 Oct 23-25 |
| Meeting Location: | Rome, Italy |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2015-10-01 |
| Start Page: | vi74 |
| End Page: | vi75 |
| Language: | English |
| ACCESSION: | WOS:000365159600231 |
| PROVIDER: | wos |
| DOI: | 10.1093/annonc/mdv343.05 |
| Notes: | Meeting Abstract: H05 -- Source: Wos |
